We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRKL
776
DELISTED
Brookline Bancorp
BRKL
$579K 0.04%
49,093
+19,910
+68% +$231K
CRM icon
777
Salesforce
CRM
$158B
$578K 0.04%
+1,728
New +$551K
WLKP icon
778
Westlake Chemical Partners
WLKP
$763M
$578K 0.04%
24,986
-621
-2% -$14.2K
VISN
779
Vistance Networks Inc
VISN
$2.52B
$577K 0.04%
+110,662
New +$619K
IBCP icon
780
Independent Bank Corp
IBCP
$844M
$577K 0.04%
+16,552
New +$587K
VST icon
781
Vistra
VST
$47.4B
$577K 0.04%
+4,183
New +$581K
LRMR icon
782
Larimar Therapeutics
LRMR
$432M
$575K 0.04%
148,533
+41,125
+38% +$271K
PLX icon
783
Protalix BioTherapeutics
PLX
$198M
$575K 0.04%
305,749
-129,464
-30% -$183K
AMRX icon
784
Amneal Pharmaceuticals
AMRX
$5.79B
$571K 0.04%
72,101
+17,751
+33% +$149K
IGMS
785
DELISTED
IGM Biosciences
IGMS
$571K 0.04%
93,482
+36,728
+65% +$436K
RUN icon
786
Sunrun
RUN
$2.46B
$571K 0.04%
61,696
+7,980
+15% +$99.1K
BRSL
787
Brightstar Lottery PLC
BRSL
$2.03B
$570K 0.04%
+32,266
New +$635K
ARW icon
788
Arrow Electronics
ARW
$10.4B
$568K 0.04%
5,020
-5,255
-51% -$649K
CPA icon
789
Copa Holdings
CPA
$5.8B
$568K 0.04%
6,459
-3,916
-38% -$371K
ET icon
790
Energy Transfer Partners
ET
$69.3B
$567K 0.04%
28,947
-60,410
-68% -$1.07M
CNDT icon
791
Conduent
CNDT
$264M
$565K 0.04%
+139,794
New +$556K
CSIQ icon
792
Canadian Solar
CSIQ
$1.08B
$564K 0.04%
+50,752
New +$655K
LPLA icon
793
LPL Financial
LPLA
$28.6B
$561K 0.04%
1,718
-1,260
-42% -$373K
MOMO
794
Hello Group
MOMO
$866M
$561K 0.04%
72,742
-88,229
-55% -$627K
TS icon
795
Tenaris
TS
$26.8B
$560K 0.04%
+14,819
New +$526K
URBN icon
796
Urban Outfitters
URBN
$6.59B
$560K 0.04%
+10,198
New +$435K
ESS icon
797
Essex Property Trust
ESS
$18.5B
$559K 0.04%
1,957
-1,441
-42% -$426K
FANG icon
798
Diamondback Energy
FANG
$52.7B
$558K 0.04%
+3,408
New +$601K
BKE icon
799
Buckle
BKE
$2.37B
$557K 0.04%
10,967
-4,759
-30% -$225K
POR icon
800
Portland General Electric
POR
$5.77B
$557K 0.04%
12,767
-3,527
-22% -$164K

Similar funds

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.